Quantum-Si (NASDAQ:QSI) Insider John Vieceli Sells 15,111 Shares

Quantum-Si Incorporated (NASDAQ:QSI) insider John Vieceli sold 15,111 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $0.96, for a total transaction of $14,506.56. Following the transaction, the insider directly owned 1,155,546 shares of the company’s stock, valued at $1,109,324.16. This represents a 1.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Quantum-Si Stock Performance

QSI stock opened at $0.83 on Thursday. The firm has a 50 day moving average price of $0.99 and a 200-day moving average price of $1.04. Quantum-Si Incorporated has a 52-week low of $0.69 and a 52-week high of $3.10. The firm has a market capitalization of $180.13 million, a price-to-earnings ratio of -1.62 and a beta of 3.18.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The company had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. As a group, sell-side analysts forecast that Quantum-Si Incorporated will post -0.49 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

A number of hedge funds have recently added to or reduced their stakes in QSI. Prudential Financial Inc. purchased a new stake in Quantum-Si during the 2nd quarter valued at $25,000. Curbstone Financial Management Corp bought a new position in shares of Quantum-Si during the fourth quarter valued at $26,000. Leonteq Securities AG bought a new position in shares of Quantum-Si during the fourth quarter valued at $28,000. Cerity Partners LLC purchased a new stake in shares of Quantum-Si during the second quarter valued at $29,000. Finally, Hollencrest Capital Management boosted its position in shares of Quantum-Si by 301.1% during the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after buying an additional 30,111 shares during the last quarter. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

QSI has been the subject of several analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a report on Friday, March 27th. Canaccord Genuity Group dropped their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $1.00.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.